Viewing StudyNCT06013943



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06013943
Status: RECRUITING
Last Update Posted: 2023-09-15
First Post: 2023-04-12

Brief Title: Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
Sponsor: Eastern Hepatobiliary Surgery Hospital
Organization: Eastern Hepatobiliary Surgery Hospital

Conditions & Keywords Data

Conditions:
Name
Gallbladder Cancer
Keywords:
Name View
Envafolimabimmune checkpoint inhibitor anti-PD-L1 antibody View